SCHEMBL6406923

SCHEMBL6406923

COC(=O)C1C(COC(c2ccccc2)c2ccccc2)C1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.41
TSHR P16473 5/20 0.40
CYP3A4 P08684 3/20 0.40
HSD17B10 Q99714 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2D6 P10635 2/20 0.40
MAPK1 P28482 1/20 0.40
ADRA1A P35348 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HTR1A P08908 2/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1B P35368 2/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 2/20 0.38
CASP1 P29466 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409612 0.87 SCN1A (0.38) HTTTSHRCYP1A2CYP2D6MAPK1
SCHEMBL6407668 0.86 TP53 (0.42) HTTTSHRCYP1A2CYP2D6ALDH1A1
SCHEMBL6406470 0.85 CTSK (0.38) HTTTSHRCYP1A2CYP2D6ADRA1A
SCHEMBL6407755 0.84 CHRM2 (0.41) CYP3A4HSD17B10CYP1A2CYP2D6ALDH1A1
SCHEMBL6406911 0.77 ALDH1A1 (0.47) HTTTSHRCYP1A2CYP2D6MAPK1
SCHEMBL6405926 0.77
SCHEMBL3362063 0.76 MMP1 (0.43) HTTTSHRCYP3A4HSD17B10CYP1A2
SCHEMBL1150157 0.76 TSHR (0.46) HTTTSHRCYP1A2MAPK1ALDH1A1
SCHEMBL6411212 0.75 HTT (0.41) HTTTSHRCYP3A4HSD17B10CYP1A2
SCHEMBL3362283 0.75 HTT (0.41) HTTHSD17B10CYP1A2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 HTT 1851/4885TSHR 1466/4885CYP3A4 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.